New research data surrounding this compound, specifically the 120mg formulation referred to as ZPHC, indicate a impressive effect on body mass decrease and related health conditions . Scientists posit that this innovative compound, targeting both GLP-1 and GIP receptors , has the potential to provide a substantial improvement in the treatment of e